Levon Bostanian PhD

Levon Bostanian PhD

Professor, College of Pharmacy

Development of novel pharmaceutical formulations for the enhanced delivery of small drug molecules.

‍

We arecurrently working on developing novel pharmaceutical formulations to enhancethe delivery of fenretinide, a drug used for the treatment of neuroblastoma inchildren. The project involves developing and in vitro and in vivotesting of the novel formulations.

‍

Education:

B.Sc. Degree in Pharmacy andPharmaceutical Sciences, University of Alexandria, Alexandria, Egypt.

M.S. in Pharmaceutics,University of Alexandria, Alexandria, Egypt.

Ph.D. in Pharmaceutics andPharmaceutical Chemistry, The Ohio State University, Columbus, OH.

‍

ORCID identifier: 0000-0001-8768-7017

‍

MyNCBI Link: https://www.ncbi.nlm.nih.gov/myncbi/levon.bostanian.1/bibliography/public/

‍

Selected Publications:

·        T. K. Mandal, L. A. Bostanian, R.A. Graves, S. R. Chapman and I. Womack, “Development of Biodegradable Microcapsules as carrier for Oral Controlled Delivery of Amifostine”, Drug. Dev. Ind. Pharm., 28(3), 339-344, 2002.

·        R. A. Graves, S. Pamujula, Moiseyev, T. Freeman, L. A. Bostanian, and T. K. Mandal, “Effect of different ratios of high and low molecular weight PLGA blend on the characteristics ofpentamidine microcapsules”, International Journal of Pharmaceutics; 270(1-2);251-262, 2004.

·        S. Pamujula, R. A Graves, R.Moiseyev, L. A. Bostanian, V. Kishore, and T. K. Mandal, “Preparation ofpolylactide-co-glycolide and chitosan hybrid microcapsules of amifostine using coaxial ultrasonic atomizer with solvent evaporation”, Journal of Pharmacy and Pharmacology, 60(3), 283 – 289, 2008.

·        S. Pamujula, R. A. Graves, T.Freeman, V. Srinivasan, L. A. Bostanian,V. Kishore, and T. K. Mandal, “Oral Delivery of Spray Dried PLGA/AmifostineNanoparticles”, Journal of Pharmacy and Pharmacology; 56, 1119-1125, 2004.

·        G. A. Ledet, R. A. Graves, E. Y. Glotser, T.K. Mandal, and L. A. Bostanian,“Preparation and In Vitro Evaluation of Hydrophilic Fenretinide Nanoparticles”.Int. J. Pharm. 479 (2): 329-337, 2015.

·        R. A. Graves, G. A. Ledet, E. Y. Glotser, L. A. Bostanian, and T. K. Mandal, “Formulation and Evaluation of Biodegradable Nanoparticles for the oral delivery of Fenretinide”. Eur. J. Pharm. Sci. 76: 1-9, 2015.

 

Topics (Keywords/Tags): Nanoparticles, fenretinide, delivery, microcapsules

‍

Link to lab website: https://www.xula.edu/mainresearch/campus-research-projects/rcmi/rcmi-core-laboratories/rcmi-drug-discovery-delivery-core.html

‍

LCRC Faculty

Missy Wooley
Population Sciences
Louisiana Tech University
Giulia Monticone, PhD
Cancer Biology
LSU Health - New Orleans
Ramsy Abdelghani, MD
Translational Oncology
Tulane University School of Medicine
Asim Abdel-Mageed DVM PhD
Translational Oncology
Tulane University School of Medicine
Jiri Adamec, PhD
Translational Oncology
LSU Health - New Orleans
Suresh K. Alahari PhD
Translational Oncology
LSU Health - New Orleans
Ashad Alam, MD, PhD
Cancer Biology
Ochsner Health
Sara Al-Dahir, PharmD, PhD, MPH
Population Sciences
Xavier University
Muralidharan Anbalagan, PhD
Translational Oncology
Tulane University School of Medicine